Global Hemostasis Diagnostics Market size is projected to reach US$ 3.77 Bn at the end of the forecast period at a CAGR of 8.27%.Hemostasis Diagnostics Market Overview:
The Hemostasis diagnostics are instruments that assist in the detection of hemostatic defects that result in excessive bleeding. Hemostasis is a protective mechanism that the body uses when it is injured. It slows blood loss and stops blood flow.To know about the Research Methodology :- Request Free Sample Report
Hemostasis Diagnostics Market Dynamics:
Hemophilia affected about 400,000 people in 2021, according to the National Hemophilia Foundation. And about 75% of people with haemophilia around the world either receive insufficient care or do not have access to treatment. As a result, the market's growth is influenced positively. The rising incidences of blood clotting diagnosis for patients, particularly those who are more vulnerable to losing excess blood from their bodies during surgeries, is one of the major factors driving the market's growth. The increased risk of older people being diagnosed with a disease is pushing up the number of operations involving hemostasis devices, such as for cardiovascular diseases (CVD). As the prevalence of diseases increases with age, the number of surgeries performed on elderly patients is increasing. During the forecast period, the market is expected to grow in demand due to the rising demand for technological advances in medical care. Government funding and increased testing, as well as rising incidences of blood clotting diagnosis for patients and a growing trend in laboratory automation, will all contribute to market development. Hemostasis diagnostics have also been automated, making them less labour intensive, faster, and easier to use. Blood coagulation analyzers, flow cytometers, microarrays, and PCR are examples of current automated technologies. The use of these technologies in combination has improved yield and productivity. The report has profiled seventeen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed and report has come up with recommendations for a future hot spot in APAC region.Segment Analysis:
The Hemostasis Diagnostics Market is segmented on the basis of Product Type, Test Type and End-Users. Based on Product Type, Point-of-care testing systems segment is expected to hold dominant market share during the forecast period. Patients and clinicians are becoming more receptive to the use of point-of-care diagnostic tests, and rising patient awareness of POC processes is fueling the market growth. In addition, one of the segmental drivers is the effective use of POC instruments for diagnosis by minimally trained professionals. POC development projects are also supported by a number of private institutions, including the California Institute of Technology, Dartmouth College, and international organizations. The American Association for Clinical Chemistry, for example, launched a certification program for POC research practitioners in August 2021 to help them develop their diagnostic testing outside of clinical laboratories. As a result, the segment is likely to grow during the forecast period.Regional Insights:
North America holds the leading share Because of the high prevalence of cardiac diseases, high healthcare expenditure, increasing knowledge for hemostasis diagnostics, and well-established healthcare infrastructure, North America holds the leading share in the market. Furthermore, the rising prevalence of a variety of blood clot disorders is driving up demand for hemostasis diagnosis. According to the data published by the National Hemophilia Foundation, nearly 20,000 Americans were diagnosed with haemophilia in 2021, boosting the demand in North America. Asia Pacific is expected to witness fastest growth during forecast period. Rising income levels in emerging economies such as China and India are leading to increased healthcare expenditure, Asia Pacific is expected to outperform all other regions in terms of growth. Furthermore, the proliferation of lifestyle-related diseases such as cancer, diabetes, and heart disease have resulted from evolving lifestyles. The report also helps in understanding Global market dynamics, structure by analyzing the market segments and project the Global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.Hemostasis Diagnostics Market Scope: Inquire Before Buying
Global Hemostasis Diagnostics Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 8.27% US$ 2.16 Bn US$ 3.77 Bn Segments Covered by Product Laboratory Systems Consumables Point-of-Care Testing Systems by Test Type Activated Partial Thromboplastin Time D Dimer Test Fibrinogen Test Prothrombin Time (PT) Test by Application Hospitals Diagnostic Centers Others Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Key Players are:
1. Abbott Laboratories 2. Thermo Fisher Scientific, Inc. 3. F. Hoffmann-La Roche Ltd. 4. Nihon Kohden Corporation 5. Sysmex Corporation 6. Siemens Healthineers 7. Instrumentation Laboratory 8. Danaher Corporation (Beckman Coulter) 9. Grifols 10. Alere Inc. 11. Roche Diagnostics 12. International Technidyne Corporation 13. Haemonetics Corporation 14. Beckman Coulter Inc. 15. Helena Labor 16. Chrono-Log 17. Axis-Shield Frequently Asked Questions: 1. Which region has the largest share in Global Hemostasis Diagnostics Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Hemostasis Diagnostics Market? Ans: The Global market is growing at a CAGR of 8.27% during forecasting period 2023-2029. 3. What is scope of the Global market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global market are – Abbott Laboratories, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Sysmex Corporation, Siemens Healthineers, Instrumentation Laboratory, Danaher Corporation (Beckman Coulter), Grifols, Alere Inc., Roche Diagnostics, International Technidyne Corporation, Haemonetics Corporation, Beckman Coulter Inc., Helena Labor, Chrono-Log, and Axis-Shield 5. What is the study period of this market? Ans: The Global market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Hemostasis Diagnostics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Hemostasis Diagnostics Market 3.4. Geographical Snapshot of the Hemostasis Diagnostics Market, By Manufacturer share 4. Global Hemostasis Diagnostics Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Hemostasis Diagnostics Market 5. Supply Side and Demand Side Indicators 6. Global Hemostasis Diagnostics Market Analysis and Forecast, 2022-2029 6.1. Global Hemostasis Diagnostics Market Size & Y-o-Y Growth Analysis. 7. Global Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 7.1.1. Laboratory Systems 7.1.2. Consumables 7.1.3. Point-of-Care Testing Systems 7.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 7.2.1. Activated Partial Thromboplastin Time 7.2.2. D Dimer Test 7.2.3. Fibrinogen Test 7.2.4. Prothrombin Time (PT) Test 7.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 7.3.1. Hospitals 7.3.2. Diagnostic Centers 7.3.3. Others 8. Global Hemostasis Diagnostics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 9.1.1. Laboratory Systems 9.1.2. Consumables 9.1.3. Point-of-Care Testing Systems 9.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 9.2.1. Activated Partial Thromboplastin Time 9.2.2. D Dimer Test 9.2.3. Fibrinogen Test 9.2.4. Prothrombin Time (PT) Test 9.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 9.3.1. Hospitals 9.3.2. Diagnostic Centers 9.3.3. Others 10. North America Hemostasis Diagnostics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 12. Canada Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 13. Mexico Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 14. Europe Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 15. Europe Hemostasis Diagnostics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 17. France Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 18. Germany Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 19. Italy Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 20. Spain Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 21. Sweden Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 22. CIS Countries Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 23. Rest of Europe Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 24. Asia Pacific Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 25. Asia Pacific Hemostasis Diagnostics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 27. India Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 28. Japan Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 29. South Korea Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 30. Australia Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 31. ASEAN Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 32. Rest of Asia Pacific Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 33. Middle East Africa Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 34. Middle East Africa Hemostasis Diagnostics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 36. GCC Countries Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 37. Egypt Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 38. Nigeria Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 39. Rest of ME&A Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 40. South America Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 41. South America Hemostasis Diagnostics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 43. Argentina Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 44. Rest of South America Hemostasis Diagnostics Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Hemostasis Diagnostics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Abbott Laboratorie 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Thermo Fisher Scientific, Inc. 45.3.3. F. Hoffmann-La Roche Ltd. 45.3.4. Nihon Kohden Corporation 45.3.5. Sysmex Corporation 45.3.6. Siemens Healthineers 45.3.7. Instrumentation Laboratory 45.3.8. Danaher Corporation (Beckman Coulter) 45.3.9. Grifols 45.3.10. Alere Inc. 45.3.11. Roche Diagnostics 45.3.12. International Technidyne Corporation 45.3.13. Haemonetics Corporation 45.3.14. Beckman Coulter Inc. 45.3.15. Helena Labor 45.3.16. Chrono-Log 45.3.17. Axis-Shield 46. Primary Key Insights